BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Sarissa Capital Management LP's Holding History (CIK: 0001577524)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 1,094,168 Value ($000) $6,762 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 1,094,168 Value ($000) $5,558 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 1,000,000 Value ($000) $5,990 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 775,000 Value ($000) $5,487 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 775,000 Value ($000) $5,456 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 775,000 Value ($000) $6,464 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 980,288 Value ($000) $11,254 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 1,390,790 Value ($000) $17,524 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 1,390,790 Value ($000) $14,715 Avg Close $10.32 Range $7.61 - $18.00
Q1 2022
Shares 1,390,790 Value ($000) $22,614 Avg Close $16.04 Range $11.56 - $19.99
Q4 2021
Shares 4,039,600 Value ($000) $55,948 Avg Close $13.23 Range $10.72 - $15.77
Q3 2021
Shares 3,926,700 Value ($000) $56,427 Avg Close $15.77 Range $14.00 - $18.48
Q2 2021
Shares 4,261,000 Value ($000) $67,366 Avg Close $13.59 Range $9.23 - $17.74
Q1 2021
Shares 7,637,700 Value ($000) $77,675 Avg Close $10.31 Range $7.27 - $14.24
Q4 2020
Shares 8,175,000 Value ($000) $60,903 Avg Close $5.16 Range $3.36 - $8.99
Q3 2020
Shares 4,861,000 Value ($000) $16,697 Avg Close $4.29 Range $3.30 - $6.03
Q2 2020
Shares 1,075,000 Value ($000) $5,122 Avg Close $3.99 Range $1.80 - $6.29